IRD CIK: 1228627

Opus Genetics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
26.1
FY22:
49.0
FY23:
53.9
FY24:
36.6
FY25:
50.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.01
FY23:
0
FY24:
0.25
FY25:
0.20
Total assets
Change from FY21 to FY25
millions USD
FY21:
26.1
FY22:
49.0
FY23:
53.9
FY24:
36.9
FY25:
50.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.86
FY22:
2.75
FY23:
4.04
FY24:
11.3
FY25:
7.78
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
27.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.2
FY22:
46.2
FY23:
49.9
FY24:
6.72
FY25:
15.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
26.1
FY22:
49.0
FY23:
53.9
FY24:
–
FY25:
50.2

All amounts in millions USD Data source:SEC EDGAR